Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on Elafibranor for Patients with Primary Biliary Cholangitis Not Responding to Ursodeoxycholic Acid
BelgiumStudy on Amantadine and Transcranial Magnetic Stimulation for Reducing Fatigue in Multiple Sclerosis Patients
SpainStudy on Long-Term Safety of Ruxolitinib, Panobinostat, and Siremadlin for Patients Continuing Treatment from Previous Studies
GermanyStudy on Vedolizumab for Patients with Active Ulcerative Colitis
BelgiumStudy on Infliximab and Tocilizumab for Patients with Refractory or Relapsing Takayasu Arteritis
FranceStudy on Long-term Benefits and Safety of DBV712 for Children with Peanut Allergy
GermanyStudy of iptacopan effectiveness in achieving remission in patients with active ANCA-associated vasculitis
AustriaStudy on Imlifidase for Highly Sensitized Patients with End-Stage Chronic Kidney Disease Awaiting Transplant
AustriaStudy on Personalized Ocrelizumab Dosing for Patients with Relapsing Remitting Multiple Sclerosis
The NetherlandsStudy on the Effectiveness and Safety of Eplontersen for Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
AustriaStudy on the Effects of Ianalumab in Adults with Rheumatoid Arthritis, Systemic Lupus Erythematosus, or Sjögren’s Disease
CzechiaStudy on BI 1015550 for Improving Lung Function in Patients with Progressive Fibrosing Interstitial Lung Diseases
AustriaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
